Head-to-head · Cost-Efficiency Index
YourEra vs Livv
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
YourEra
Shoppers chasing the lowest sticker price who will verify what's actually billed after the first month.
Visit YourEraLivv
Cost-first shoppers who want a flat price that doesn't rise as the GLP-1 dose is titrated upward.
Visit LivvThe verdict
Livv takes it, leading the Cost-Efficiency Index 64 to 62. Livv is a telehealth platform selling compounded semaglutide and tirzepatide at a flat, dose-independent price — $135/month and $199/month respectively — bundling the consultation, medication, supplies and shipping. YourEra still earns a C — Shoppers chasing the lowest sticker price who will verify what's actually billed after the first month.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Livv.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | YourEra | Livv |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 64/100 |
| Semaglutide / mo | $179/mo (all doses, month-to-month, compounded) | $135/mo (all doses, compounded) |
| Tirzepatide / mo | $259/mo (all doses, month-to-month, compounded) | $199/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,148 | $1,620 |
| Tirzepatide / yr (modeled) | $3,108 | $2,388 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #171 | #178 |
YourEra
62/100Where the value is
- A 6-month prepay drops semaglutide to $99/month, among the lowest compounded-GLP-1 headline prices we track
- No membership-fee structure; the site markets "no hidden fees" and "Same price at every dose"
- Prescriptions are "issued only if deemed medically appropriate" after evaluation by licensed US clinicians, stated plainly
The tradeoffs
- The advertised $99/month requires a 6-month prepay — paying month to month costs $149 for the first month and $179/month after, nearly double the headline
- Tirzepatide's advertised $179 is a first-month intro, not a prepay rung: the page's own words are "Month-to-month intro. Then $259/mo." — so the two molecules' headline discounts work in two different ways on one page
Livv
64/100Where the value is
- Dose-independent flat pricing — the site explicitly commits that cost won't rise as the dose is adjusted, which is unusual among compounded-GLP-1 competitors
- One published price bundles consultation, medication, supplies, shipping and follow-ups with 'no hidden fees' language
- LegitScript verified
The tradeoffs
- Not available in all 50 states, and the site does not list which states are excluded
- No compounding pharmacy name or medical director is disclosed anywhere I could find
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.